We first confirmed that loss of C2ORF40 protein expression was found correlated with the clinicopathologic characteristics of human breast cancer using our clinical samples and restoration of C2ORF40 arrested cancer cell cycle progression at M phase by cell cycle synchronization techniques. Here, ECRG4 is linked to breast cancer.